0001493152-22-022804.txt : 20220815 0001493152-22-022804.hdr.sgml : 20220815 20220815150353 ACCESSION NUMBER: 0001493152-22-022804 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220727 FILED AS OF DATE: 20220815 DATE AS OF CHANGE: 20220815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: 10X Fund, L.P. CENTRAL INDEX KEY: 0001453356 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-31791 FILM NUMBER: 221165080 BUSINESS ADDRESS: STREET 1: 1099 FOREST LAKE TERRACE CITY: NICEVILLE STATE: FL ZIP: 32578 BUSINESS PHONE: 208-263-6695 MAIL ADDRESS: STREET 1: 1099 FOREST LAKE TERRACE CITY: NICEVILLE STATE: FL ZIP: 32578 FORMER NAME: FORMER CONFORMED NAME: 10X FUND LP DATE OF NAME CHANGE: 20090107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC CENTRAL INDEX KEY: 0001133416 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043562325 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD STREET 2: SUITE 240 CITY: NORCROSS STATE: GA ZIP: 30071 BUSINESS PHONE: 678-620-3186 MAIL ADDRESS: STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD STREET 2: SUITE 240 CITY: NORCROSS STATE: GA ZIP: 30071 FORMER COMPANY: FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010612 4/A 1 ownership.xml X0306 4/A 2022-07-27 2022-08-09 0 0001133416 GALECTIN THERAPEUTICS INC GALT 0001453356 10X Fund, L.P. 545 DUTCH VALLEY ROAD, N.E., SUITE A ATLANTA, GA 30324 0 0 1 0 Common Stock 2022-07-27 4 S 0 10000 2.087 D 6168940 D Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan. 10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. /s/ James C. Czirr, as Managing Member of the General Partner for 10X Fund, LP 2022-08-12 /s/ James C. Czirr, as Managing Member of 10X Capital Management, LLC 2022-08-12 /s/ James C. Czirr, Individually 2022-08-12